Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 5,000 | 10,000 | 16,684 | 17,571 | 15,838 |
| Gross Profit | 5,000 | 10,000 | 16,684 | 17,571 | 15,838 |
| Operating Expenses | 71,722 | 38,781 | 19,709 | 20,893 | 10,968 |
| Operating Income | -66,722 | -28,781 | -3,025 | -3,322 | 4,870 |
| Interest Expense | 1,652 | 1,775 | 458 | 460 | 1,281 |
| Other Income | 6,526 | 486 | -776 | -1,484 | -57 |
| Pre-tax Income | -61,848 | -30,070 | -4,259 | -5,266 | 3,532 |
| Income Tax | -192 | N/A | N/A | 139 | N/A |
| Net Income Continuous | -61,656 | -30,070 | -4,259 | -5,405 | 3,532 |
| Net Income | $-61,656 | $-30,070 | $-4,259 | $-5,405 | $3,532 |
| EPS Basic Total Ops | -2.50 | -1.52 | -1.62 | -2.12 | 0.09 |
| EPS Basic Continuous Ops | -2.50 | -1.52 | -1.62 | -2.12 | 1.42 |
| EPS Diluted Total Ops | -2.50 | -1.52 | -1.62 | -2.12 | 0.09 |
| EPS Diluted Continuous Ops | -2.50 | -1.52 | -1.62 | -2.12 | 1.42 |
| EPS Diluted Before Non-Recurring Items | -2.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-67,640 | $-28,598 | $-2,792 | $-3,048 | $5,178 |